Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...

The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

This partnership brings together Remidio’s Medios DR AI for automated DR detection and RetinaRisk’s personalised risk ...

Diabetes affects more than 101 million people in India today. The number is estimated to reach 125 million by the year 2045.

With vision loss due to diabetes emerging as one of the most serious yet overlooked complications in India, Firstpost brings ...

Dr. Mohan’s Diabetes Specialities Centre (DMDSC) on Tuesday launched an AI-driven software to detect diabetic retinopathy at its Thanjavur Centre ...

Diabetic retinopathy (DR), a serious eye condition caused by damage to the blood vessels in the retina—the light-sensitive tissue at the back of the eye—is a ma ...

Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections ...

India's first AI-driven software by Dr. Mohan's Diabetes Specialities Centre detects early retinal damage for improved patient outcomes.

Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain.

A drop of your tears may soon be enough to save your sight, thanks to a team of researchers at Pondicherry University.